Liang-Yu Lin, MD, PhD

Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, Taiwan (Republic of China)

Poster(s):

• (SLC-003) Sodium-Glucose Co-Transporter-2 Inhibitor Use and Risks of Exacerbation and Pneumonia in Patients with Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Population-Based Cohort Study
  Tuesday, August 26, 2025

  12:15 PM - 1:15 PM ET